Search company, investor...
Bio-Me company logo


Founded Year



Seed | Alive

Total Raised


Last Raised

$1.13M | 1 yr ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+90 points in the past 30 days

About Bio-Me

Bio-Me develops the Precision Microbiome Profiling (PMP) platform to enable microbiome-based companion diagnostics and the discovery of drug targets to improve health and wellbeing. Its qPCR-based platform focuses on microbiome analysis by enabling high-volume precision microbiome profiling. The company was founded in 2016 and is based in Oslo, Norway.

Headquarters Location

Gaustadalléen 21

Oslo, 0349,


+47 21 09 03 02

Missing: Bio-Me's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Bio-Me's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Bio-Me

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Bio-Me is included in 5 Expert Collections, including Omics.



275 items


Medical Devices

8,560 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

76 items

Companies developing companion diagnostics and technology enabling the development of companion diagnostics. Tagged as #CompanionDx


Biopharma Tech

838 items


Health IT

7,901 items

Bio-Me Patents

Bio-Me has filed 1 patent.

The 3 most popular patent topics include:

  • Digestive system surgery
  • Surgery
  • Surgical removal procedures
patents chart

Application Date

Grant Date


Related Topics




Digestive system surgery, Dosage forms, Endoscopy, Drug delivery devices, Molecular biology


Application Date


Grant Date



Related Topics

Digestive system surgery, Dosage forms, Endoscopy, Drug delivery devices, Molecular biology



Latest Bio-Me News

Bio-Me Raises NOK 10M for Microbiome Precision Medicine

Jul 6, 2021

Save for later NEW YORK – Norwegain firm Bio-Me announced Tuesday it has raised 10 million Norwegian kroner ($1.2 million) to support its microbiome-based precision medicine clinical programs. The firm noted in a statement that existing and new investors participated, with new investors contributing the majority of the capital. Bio-Me said it will use the funding to advance several clinical programs and explore other business opportunities for shorter-term revenue generation. Oslo -based Bio-Me has developed an analysis tool for the gut microbiome in collaboration with Thermo Fischer Scientific. Called Precision Microbiome Profiling , the tool uses qPCR to enable analysis of up to 200 samples in two hours, allowing to the testing to potentially meet the requirements for clinical diagnostic applications. "The successful funding round is an important step towards positioning Bio-Me for further growth and being a leader in microbiome-based precision medicine," said Bio-Me CEO Morten Isaksen in a statement. The firm was awarded €2 million ($2.2 million) last year from the Norwegian Research Council to develop a companion diagnostic test for immune checkpoint inhibitor cancer treatments. Bio-Me is also collaborating with San Carlos, California-based Siolta Therapeutics to develop a rapid diagnostic test for newborns at risk of developing allergy and asthma, and is collaborating on a study of the long-term effects of COVID-19 infection on the gut microbiome in adolescents.

Bio-Me Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Bio-Me Rank

Bio-Me Frequently Asked Questions (FAQ)

  • When was Bio-Me founded?

    Bio-Me was founded in 2016.

  • Where is Bio-Me's headquarters?

    Bio-Me's headquarters is located at Gaustadalléen 21, Oslo.

  • What is Bio-Me's latest funding round?

    Bio-Me's latest funding round is Seed.

  • How much did Bio-Me raise?

    Bio-Me raised a total of $3.29M.

  • Who are the investors of Bio-Me?

    Investors of Bio-Me include Norges Forskningsråd and TRK Group.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.